NCT02151591View on ClinicalTrials.gov

New Approaches to Smoking Cessation in Heavy Drinkers

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

June 1, 2018

Study Completion Date

August 1, 2018

Conditions
Nicotine DependenceCigarette SmokingAlcohol ConsumptionHeavy Drinking
Interventions
DRUG

Varenicline

"12-weeks of treatment. Dose will be titrated as follows:~Days 1-3: 1 0.5mg tablet once per day Days 4-7: 1 0.5mg tablet twice per day Day 8 - Week 11: 1 1mg tablet twice per day"

Trial Locations (1)

06511

Yale University School of Medicine, New Haven

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Yale University

OTHER

NCT02151591 - New Approaches to Smoking Cessation in Heavy Drinkers | Biotech Hunter | Biotech Hunter